DocGo
Stock Forecast, Prediction & Price Target
DocGo Financial Estimates
DocGo Revenue Estimates
DocGo EBITDA Estimates
DocGo Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $318.71M N/A | $440.51M 38.21% | $624.28M 41.71% | Avg: $466.39M Low: $443.76M High: $481.18M avg. -25.29% | Avg: $439.30M Low: $420.44M High: $458.72M avg. -5.80% | ||
Net Income
% change YoY
| $23.74M N/A | $34.58M 45.65% | $6.85M -80.16% | Avg: $27.22M Low: $7.38M High: $61.24M avg. 296.89% | Avg: $38.92M Low: $35.75M High: $40.04M avg. 43.00% | ||
EBITDA
% change YoY
| $17.56M N/A | $34.21M 94.82% | $31.75M -7.19% | Avg: $-24.59M Low: $-25.37M High: $-23.40M avg. -177.46% | Avg: $-23.16M Low: $-24.19M High: $-22.17M avg. 5.80% | ||
EPS
% change YoY
| $0.3 N/A | $0.34 13.33% | $0.07 -80.5% | Avg: $0.22 Low: $0.07 High: $0.58 avg. 234.32% | Avg: $0.36 Low: $0.34 High: $0.38 avg. 61.76% | ||
Operating Expenses
% change YoY
| $94.39M N/A | $132.88M 40.78% | $180.32M 35.69% | Avg: $166.28M Low: $158.21M High: $171.55M avg. -7.78% | Avg: $156.62M Low: $149.90M High: $163.55M avg. -5.80% | ||
FAQ
What is DocGo stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 169.94% in 2025-2026.
We have gathered data from 4 analysts. Their low estimate is 7.38M, average is 27.22M and high is 61.24M.
What is DocGo stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -15.55% in 2025-2026.
We have gathered data from 5 analysts. Their low revenue estimate is $443.76M, average is $466.39M and high is $481.18M.
What is DocGo stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 148.04% in 2025-2026.
We have gathered data from 4 analysts. Their low earnings per share estimate is $0.07, average is $0.22 and high is $0.57.
What is the best performing analyst?
In the last twelve months analysts have been covering DocGo stock. The most successful analyst is David Grossman.